Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in The post Steps to building...
With the Biotechnology space rotating toward a more acquisition friendly dynamic, investors may benefit from a studied focus on likely takeout candidates...
On Thursday, 17 November, Reuters opened the doors for its first European awards ceremony. The event brought together The post AstraZeneca leads winners...
'Negative Efficacy' Should Have Stopped COVID Vaccine Recommendations In Their Tracks Authored by Dr. Sean Lin and Mingjia Jacky Guan via...
The expanded platform will enable Oxford-based Exscientia to develop next-generation therapeutic antibodies through generative AI design—from computationally...
...
Scientists in the US say they have developed an mRNA-based vaccine that encompasses all 20 known subtypes of The post mRNA can deliver universal flu vaccine,...
"Grade-A Gaslighting": FDA Says Anti-Ivermectin Campaign Was 'Just A Recommendation' The US Food and Drug Administration (FDA), which mocked...
The COVID-19 pandemic stopped the world in its tracks. It provided a range of new challenges for industry The post Overcoming the challenges of developing...
CytoDyn Inc (OTCMKTS: CYDY) has formed a solid base over $0.30 and is beginning to move northbound again. The stock recently made a solid bounce from...
Respiratory syncytial virus may be common, but it can lead to severe infection in some children.
Credit: IVI SK bioscience, IVI convene consultative meeting to discuss cooperation for next pandemic Company announces KRW3 billion donation to IVI...
*A PRESS BRIEFING ORGANISED BY THE EUROPEAN CANCER ORGANISATION WILL BE HELD AT 10:30AM GMT / 11:30AM CET MONDAY 14TH NOVEMBER* Contact marilena.madsen@europeancancer.org...
Organicell Regenerative Medicine Inc (OTCMKTS: OCEL) is making an explosive move up the charts after the Company announced the Mayo Clinic will be the...
Nascent Biotech Inc. (OTCMKTS:NBIO) is an emerging player in the $4 billion oncology drug development space. NBIO is early-stage – its flagship drug...
Two and a half years ago, Covid-19 began to infect hundreds, then thousands, then millions of people, and The post Propelling clinical research into the...
A multidisciplinary team of Weill Cornell Medicine researchers have received a five-year $5.7 million grant from the National Cancer Institute at the...
The lack of diversity in clinical trials has been a topic of debate for decades, but was thrust The post IQVIA’s report card for clinical trial...
As part of our Women in Pharma series, where we talk to leading figures in the life sciences, The post Spotlight on women in pharma: Şeyda...
Codonopsis lanceolata, more commonly referred to as “deodeok”, is used as a medicinal herb in South Korea. It is cultivated in large quantities...
To continue with pharmaphorum’s coverage of Day One of The Economist’s 8th Annual World Cancer Series congress in The post Economist Impact: World...
Three different nanoparticles featuring high porosity were examined: a cyclodextrin-based nanoparticle, a porous magnesium phosphate nanoparticle, and...
Due to the pandemic, decentralised trial solutions made the shift from an emerging trend to a crucial element The post Pandemic boost to decentralised...
Significant immunological differences between young men and women were shown to mediate sex differences in the responses to the virus that causes COVID-19,...
These types of vaccines could offer certain advantages over conventional COVID shots. But we need more data to show us they’re effective.
Christian Olsen, PhD, business segment lead at Dotmatics, discusses the balancing act needed to succeed at the fulcrum of the incredible potential that...
Medical Board Moves To Strip Dr. Peter McCullough Of Certifications Authored by Zachary Stieber via The Epoch Times (emphasis ours), A medical...
Last month, as cell therapy player Allogene launched a study for its candidate targeting large B-cell lymphoma, the company put the finishing touches on...
In a candid conversation with GEN senior science writer Julianna LeMieux during “The State of Biotech” forum, Nobel Laureate Doudna discussed a wide...
Citeline and Norstella have completed a merger, first announced in June, to create one of the largest players The post Norstella, Citeline merge to create...